BR9612549A - Método para tratamento de agressão excessiva - Google Patents

Método para tratamento de agressão excessiva

Info

Publication number
BR9612549A
BR9612549A BR9612549A BR9612549A BR9612549A BR 9612549 A BR9612549 A BR 9612549A BR 9612549 A BR9612549 A BR 9612549A BR 9612549 A BR9612549 A BR 9612549A BR 9612549 A BR9612549 A BR 9612549A
Authority
BR
Brazil
Prior art keywords
treating excessive
excessive aggression
aggression
treating
olanzapine
Prior art date
Application number
BR9612549A
Other languages
English (en)
Inventor
Charles M Beasley Jr
Pierre V Tran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9612549A publication Critical patent/BR9612549A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyrane Compounds (AREA)
BR9612549A 1996-03-11 1996-12-04 Método para tratamento de agressão excessiva BR9612549A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312796P 1996-03-11 1996-03-11
PCT/US1996/019573 WO1997033584A1 (en) 1996-03-11 1996-12-04 Method for treating excessive aggression

Publications (1)

Publication Number Publication Date
BR9612549A true BR9612549A (pt) 1999-07-20

Family

ID=21758447

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612549A BR9612549A (pt) 1996-03-11 1996-12-04 Método para tratamento de agressão excessiva

Country Status (22)

Country Link
EP (1) EP0900085B1 (pt)
JP (1) JP2000506858A (pt)
KR (1) KR19990087716A (pt)
CN (1) CN1124847C (pt)
AT (1) ATE306269T1 (pt)
AU (1) AU719517B2 (pt)
BR (1) BR9612549A (pt)
CA (1) CA2248753C (pt)
CZ (1) CZ296579B6 (pt)
DE (1) DE69635282T2 (pt)
DK (1) DK0900085T3 (pt)
EA (1) EA000741B1 (pt)
ES (1) ES2249789T3 (pt)
HU (1) HUP9903685A3 (pt)
IL (1) IL126157A (pt)
NO (1) NO323579B1 (pt)
NZ (1) NZ325035A (pt)
PL (1) PL186975B1 (pt)
RO (1) RO117347B1 (pt)
TR (1) TR199801799T2 (pt)
UA (1) UA57727C2 (pt)
WO (1) WO1997033584A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
JP2002530341A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
AU707858B2 (en) * 1995-05-30 1999-07-22 Eli Lilly And Company Method for treating cognitive dysfunction

Also Published As

Publication number Publication date
CZ296579B6 (cs) 2006-04-12
AU719517B2 (en) 2000-05-11
EP0900085A1 (en) 1999-03-10
JP2000506858A (ja) 2000-06-06
EP0900085A4 (en) 2000-12-13
HUP9903685A2 (hu) 2000-03-28
NO984198D0 (no) 1998-09-11
WO1997033584A1 (en) 1997-09-18
IL126157A0 (en) 1999-05-09
CA2248753A1 (en) 1997-09-18
KR19990087716A (ko) 1999-12-27
ES2249789T3 (es) 2006-04-01
CA2248753C (en) 2008-11-18
TR199801799T2 (xx) 1999-01-18
IL126157A (en) 2002-09-12
PL328949A1 (en) 1999-03-01
CZ290598A3 (cs) 1999-09-15
AU1284697A (en) 1997-10-01
PL186975B1 (pl) 2004-04-30
NZ325035A (en) 2001-06-29
UA57727C2 (uk) 2003-07-15
RO117347B1 (ro) 2002-02-28
EA199800822A1 (ru) 1999-02-25
DE69635282D1 (de) 2006-02-23
ATE306269T1 (de) 2005-10-15
DK0900085T3 (da) 2006-01-30
NO323579B1 (no) 2007-06-11
CN1124847C (zh) 2003-10-22
DE69635282T2 (de) 2006-04-20
CN1213969A (zh) 1999-04-14
NO984198L (no) 1998-11-02
EP0900085B1 (en) 2005-10-12
HUP9903685A3 (en) 2001-12-28
EA000741B1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
EA199800667A1 (ru) Новые фенантридины
EA199800866A1 (ru) Способ снятия боли
BR9612549A (pt) Método para tratamento de agressão excessiva
FR2786100B1 (fr) Nouvelle application therapeutique de la nicergoline
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO20005548D0 (no) Mykobakterieinhibitorer
BR9708037A (pt) Método para o tratamento de abuso de substância
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
EA199800818A1 (ru) Способ лечения бессонницы
YU40198A (sh) Postupak za tretiranje zavisnosti od supstance
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
BR9709007A (pt) Uso de azaspirano substituìdo no tratamento da asma.
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
UA25833C2 (uk) Засіб для лікуваhhя мелаhомобластом
ES1031273Y (es) Protector desechable para talones y codos en pacientes encamados.
UA25399A (uk) Спосіб лікуваhhя хворих гломерулоhефритом

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.